Agreed, and that's what Matt said too. Paraphrasing here now, but something like "we are not interested in doing the usual ASX surge and dump in SP", this will only benefit traders, not LTH's. He is building a commercially viable company which will be reflected in a high stable SP based on real earnings.
Bring on the FDA sign off on SB next year and we'll see what the SP is then.
Ann: Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea, page-51
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.020(6.25%) |
Mkt cap ! $617.9M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 34.3¢ | 32.5¢ | $1.814M | 5.424M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 489055 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 340303 | 4 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |